Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Dermatology

Free Subscription 15.06.2026 7 Br J Dermatol 1 Cancer 1 Cancer Lett 2 Cancer Res 3 Clin Dermatol 4 Clin Exp Dermatol 19 Dermatol Online J 1 Hum Mutat 15 Int J Dermatol 3 J Cutan Pathol 8 J Dermatol 14 J Invest Dermatol 2 Mycoses 11 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Br J Dermatol

1. STEIJLEN OFM, Rentroia-Pacheco B, Tokez S, Amir AL, et al
   Expanding histopathological assessment may provide limited prognostic value for metastatic cutaneous squamous cell carcinoma: insights from two nationwide nested case-control studies.
   Br J Dermatol. 2026 Jun 12:ljag227. doi: 10.1093.
   PubMed         Abstract available
   
   
2. ASSAN F, Miskinyte S, Sylvain S, Masson Regnault M, et al
   Psoriasis flare-ups in non syndromic autosomal recessive epidermal differentiation disorders.
   Br J Dermatol. 2026 Jun 11:ljag244. doi: 10.1093.
   PubMed        
   
   
3. KNOPS E, Spuls PI
   Comparing narrowband and broadband ultraviolet B for atopic dermatitis: new knowledge about an "old" therapy.
   Br J Dermatol. 2026 Jun 10:ljag230. doi: 10.1093.
   PubMed        
   
   
4. CHIU YC, Ma SH, Chen TL
   Treatments for Pediatric Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Critical Appraisal and Systematic Review.
   Br J Dermatol. 2026 Jun 10:ljag237. doi: 10.1093.
   PubMed        
   
   
5. NIE Y, Waller H, Caley MP, Peters DT, et al
   Engineered Caf1 Constructs Encoding Laminin-332 Motifs: A Novel Approach for Enhanced Cutaneous Wound Healing.
   Br J Dermatol. 2026 Jun 9:ljag235. doi: 10.1093.
   PubMed         Abstract available
   
   
6. YIU ZZN, Wilson ECF
   The US-UK pharmaceutical deal - do dermatologists have skin in the game?
   Br J Dermatol. 2026 Jun 8:ljag236. doi: 10.1093.
   PubMed        
   
   
7. BOADA A, Tejera-Vaquerizo A
   Melanoma diagnosis during COVID-19: delay, disruption and the question of overdiagnosis.
   Br J Dermatol. 2026 Jun 7:ljag234. doi: 10.1093.
   PubMed        
   
   

   
   Cancer

8. BEASLEY HK, Shah T, Tinker RJ, Weidner A, et al
   Clinicopathologic characteristics of early-onset breast cancer among unselected young Black women.
   Cancer. 2026;132:e70402.
   PubMed         Abstract available
   
   

   
   Cancer Lett

9. MA S, Chen M, Sun X, Wei B, et al
   Tamoxifen enhances radiation efficacy by promoting M1 polarization of tumor associated macrophages via JNK/c-JUN pathway.
   Cancer Lett. 2026;655:218609.
   PubMed         Abstract available
   
   

   
   Cancer Res

10. YEVDASH JI, Robinson D, Moore R, Li Z, et al
    GNAQ Induces Melanomagenesis in Mitfa-Independent Melanocyte Progenitors in a Zebrafish Model of Uveal Melanoma.
    Cancer Res. 2026 Jun 10. doi: 10.1158/0008-5472.CAN-25-5299.
    PubMed         Abstract available
    
    
11. KREUGER IZM, Merkus VA, de Haan S, Schrader AMR, et al
    Spatial Analysis Reveals Gene Expression and Microenvironmental Changes in the Transition of Nevus to Melanoma.
    Cancer Res. 2026 Jun 8. doi: 10.1158/0008-5472.CAN-25-2934.
    PubMed         Abstract available
    
    

    
    Clin Dermatol

12. CHIRIAC AE, Pinteala T, Chiriac A, Wollina U, et al
    Involvement of the External Ear by inflammatory Skin Diseases.
    Clin Dermatol. 2026 Jun 4:S0738-081X(26)00143.
    PubMed         Abstract available
    
    
13. WOLLINA U, Karadag AS
    Algorithmic approach to skin diseases of the ear.
    Clin Dermatol. 2026 Jun 4:S0738-081X(26)00141.
    PubMed         Abstract available
    
    
14. COHEN PR
    Discovery of an Intravenous Drug Injection Site: A Meticulous Cutaneous Examination Provides the Forensic Dermatology Clue to a Diagnosis of Homicide.
    Clin Dermatol. 2026 Jun 10:S0738-081X(26)00150.
    PubMed         Abstract available
    
    

    
    Clin Exp Dermatol

15. XU X, Wang R, Zhang Q, Zou Y, et al
    Comment on 'Testing patterns, patient and tumour characteristics and survival by NRAS and KIT genotype in melanoma': can survival associations be inferred from selectively tested populations?
    Clin Exp Dermatol. 2026 Jun 10:llag246. doi: 10.1093.
    PubMed        
    
    
16. XU X, Wang R, Zhang Q, Zou Y, et al
    Comment on 'Lebrikizumab provides stable skin response with no or minimal fluctuations for up to 2 years in patients with atopic dermatitis': Does persistence among responders equal durable disease control?
    Clin Exp Dermatol. 2026 Jun 10:llag244. doi: 10.1093.
    PubMed        
    
    
17. CALIGIURE A, Kaja E, Guglielmo A, De Martino A, et al
    Tumor-field predominant bullous pemphigoid in a patient with metastatic melanoma.
    Clin Exp Dermatol. 2026 Jun 9:llag243. doi: 10.1093.
    PubMed        
    
    
18. TIAN Y, Li M, Hong H, Feng R, et al
    Comparative pharmacovigilance of herpetic infections with dupilumab and JAK inhibitors in atopic dermatitis.
    Clin Exp Dermatol. 2026 Jun 8:llag242. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Dermatol Online J

19. GORENA C, Baird E, Malone J, Schadt CR, et al
    Necrobiotic xanthogranuloma: Highlighting the role of clinicopathologic correlation in an atypical presentation.
    Dermatol Online J. 2026;32.
    PubMed         Abstract available
    
    
20. JOHNSON M, Clark M, Whittington C, Newton E, et al
    Adverse dermatologic effects of erdafitinib in a patient with metastatic urothelial carcinoma.
    Dermatol Online J. 2026;32.
    PubMed         Abstract available
    
    
21. NOVIANDARI HA, Rayinda T, Agustin M, Santosa J, et al
    Crusted scabies in patients with recessive dystrophic epidermolysis bullosa.
    Dermatol Online J. 2026;32.
    PubMed         Abstract available
    
    
22. MONROE J, Gaghan LJ, Kawaoka J, Bostom LR, et al
    Cystic panfolliculoma of the conchal bowl.
    Dermatol Online J. 2026;32.
    PubMed         Abstract available
    
    
23. HOJJAT C, Jhingan I, Veon FL, McBride J, et al
    Epithelioid angiosarcoma of the scalp: An advanced and rare presentation.
    Dermatol Online J. 2026;32.
    PubMed         Abstract available
    
    
24. ZENELI V, Zeneli A, Vasili E, Dedej S, et al
    Reactive eccrine syringofibroadenoma in an elderly patient.
    Dermatol Online J. 2026;32.
    PubMed         Abstract available
    
    
25. ROBLEDO MO, Parra MJG, Linthon SA, Villamizar ME, et al
    Dermoscopy and trichoscopy in Klippel-Trenaunay syndrome.
    Dermatol Online J. 2026;32.
    PubMed         Abstract available
    
    
26. LIU JY, Scumpia P, Ni C, Yashar S, et al
    A diagnostically challenging case of pemphigus foliaceus without histologic evidence of acantholysis.
    Dermatol Online J. 2026;32.
    PubMed         Abstract available
    
    
27. HUSSEINALI M, Engineer N, Asempa O
    Cardiometabolic comorbidities associated with androgenetic alopecia: Findings from a sex-stratified, propensity-matched national cohort.
    Dermatol Online J. 2026;32.
    PubMed         Abstract available
    
    
28. BRAZAO C, Borges-Costa J, Antunes-Duarte S, Mancha D, et al
    A New World disease: Dual diagnostic challenges in travelers returning from Costa Rica.
    Dermatol Online J. 2026;31.
    PubMed         Abstract available
    
    
29. BIMBI C, Nichele A, Cezar JPL, Machado C, et al
    Aquagenic wrinkling of the palms in a healthy adolescent.
    Dermatol Online J. 2026;31.
    PubMed         Abstract available
    
    
30. NAYAK R, Laga AC, Kenyon AL, Shi CR, et al
    Patchy presentation of central centrifugal cicatricial alopecia.
    Dermatol Online J. 2026;31.
    PubMed         Abstract available
    
    
31. GRANJA BV, Marques C
    Applicability of bilobed transposition flaps in extranasal locations.
    Dermatol Online J. 2026;31.
    PubMed         Abstract available
    
    
32. SALMEN NL, Pong TM, Bennett S, Cook DL, et al
    Disguised discoloration: Minocycline-induced pigmented cardiac valves.
    Dermatol Online J. 2026;31.
    PubMed         Abstract available
    
    
33. ARNAIZ-CAMACHO A, Puig-Galy J, Martin-Nalda S, Bisbe-Lopez L, et al
    Severe exposure keratopathy secondary to oncologic surgery in a patient with epidermodysplasia verruciformis.
    Dermatol Online J. 2026;31.
    PubMed         Abstract available
    
    
34. MIN M, Khalfe Y, Leung B, Huttenbach Y, et al
    Multibacillary leprosy relapse presenting as hypopigmented patches and concurrent erythema nodosum leprosum after initial multidrug therapy.
    Dermatol Online J. 2026;31.
    PubMed         Abstract available
    
    
35. MCGRATH LN, Mikulinsky A, Feldman SR
    Scalp cooling and chemotherapy-induced alopecia: Evaluating cost-effectiveness and insurance coverage.
    Dermatol Online J. 2026;31.
    PubMed         Abstract available
    
    
36. MANDUCA S, Jairath N, Flamm A, Adotama P, et al
    Complement fragment 4d staining as a potential diagnostic tool for bullous disorders with esophageal involvement.
    Dermatol Online J. 2026;31.
    PubMed         Abstract available
    
    
37. GAO DX, Plotnikova NE
    Surgical site infection with Mycobacterium fortuitum following Mohs micrographic surgery in an immunocompromised patient and review.
    Dermatol Online J. 2026;32.
    PubMed         Abstract available
    
    

    
    Hum Mutat

38. WANG X, Ding Y, Cai W, Liu C, et al
    YIF1B Mutational Dysregulation Drives Cutaneous Melanoma Progression by Remodeling the TME.
    Hum Mutat. 2026;2026:8907583.
    PubMed         Abstract available
    
    

    
    Int J Dermatol

39. CRAVER AE, Damsky W, Cohen JM
    Atopic Dermatitis and Celiac Disease: A Study of US Adults in the NIH All of US Research Program.
    Int J Dermatol. 2026 Jun 8. doi: 10.1111/ijd.70521.
    PubMed        
    
    
40. GALLO G, Quaglino P, Ribero S
    Beyond the Kidney and Lung: Cutaneous and Mucosal Clues to Human Hantavirus Disease.
    Int J Dermatol. 2026 Jun 9. doi: 10.1111/ijd.70523.
    PubMed         Abstract available
    
    
41. KUTLUBAY Z, Ergun MG, Ozkoca D
    The Therapeutic Potential of Intravenous Exosomes in the Treatment of Psoriasis.
    Int J Dermatol. 2026 Jun 10. doi: 10.1111/ijd.70541.
    PubMed        
    
    
42. MEDURI AR, Mura MD, Sorino J, Cazzato G, et al
    Ochre Fluorescence in Melanoma Under Ultraviolet-Induced Fluorescence Dermoscopy: A Case Series.
    Int J Dermatol. 2026 Jun 10. doi: 10.1111/ijd.70510.
    PubMed        
    
    
43. MART HME, Akay BN
    Absence of Ochre Fluorescence in Acral Melanoma Under Ultraviolet Dermoscopy.
    Int J Dermatol. 2026 Jun 10. doi: 10.1111/ijd.70539.
    PubMed        
    
    
44. CHOI ME, Jung JM, Jeon SH, Won CH, et al
    Prognostic Value of Skin Lesion Characteristics in Subcutaneous Panniculitis-Like T-Cell Lymphoma: A Retrospective Cohort Study Assessing the Applicability of T Category of the TNM Classification for Primary Cutaneous Lymphomas Other Than Mycosis Fung
    Int J Dermatol. 2026 Jun 11. doi: 10.1111/ijd.70532.
    PubMed         Abstract available
    
    
45. JIANG X, Luo AJ, Preda-Namescu A, Lefebvre M, et al
    A 73-Year-Old Man With Eruptive Pruritic Brown Papules.
    Int J Dermatol. 2026 Jun 11. doi: 10.1111/ijd.70525.
    PubMed         Abstract available
    
    
46. GROCHOWSKA-RAK M, Kulig K, Grabowska A, Karlinska-Jonkisz V, et al
    Sensitivity and Specificity of ELISA Tests Detecting BP180 and BP230 Antibodies in the Diagnosis of Bullous Pemphigoid: A Systematic Review and Meta-Analysis.
    Int J Dermatol. 2026;65:1367-1375.
    PubMed         Abstract available
    
    
47. GALILI E, Kotek O, Shemer A, Snast I, et al
    Intraoperative Nail Matrix Assessment in Longitudinal Melanonychia.
    Int J Dermatol. 2026;65:1450-1456.
    PubMed         Abstract available
    
    
48. ATTARD Z, Borg Grech S, Pisani D, Scerri L, et al
    A Widespread Pruritic Blistering Eruption in a Young Female.
    Int J Dermatol. 2026;65:1363-1366.
    PubMed         Abstract available
    
    
49. LEKIC B, Bonaci-Nikolic B, Lalosevic J, Jovanovic D, et al
    Anti-Desmoglein 3 Avidity Correlates Better With Pemphigus Vulgaris Severity Than Anti-Desmoglein 3 Concentration.
    Int J Dermatol. 2026;65:1410-1419.
    PubMed         Abstract available
    
    
50. DIENES S, Esfandiari N, Daveluy S
    Mucous Membrane Pemphigoid After Anti-PD-1 Therapy: Risk-Stratified Management and Treatment Outcomes.
    Int J Dermatol. 2026;65:1376-1382.
    PubMed         Abstract available
    
    
51. MAGLIE R, Didona D, Collina MC, Antiga E, et al
    Optimizing Local Treatment in Pemphigus and Pemphigoid: Current Evidence and Unmet Needs.
    Int J Dermatol. 2026;65:1383-1394.
    PubMed         Abstract available
    
    
52. ZOU M, Feng X, Zhan K, Wang H, et al
    Autoimmune Bullous Diseases Associated With Immune Checkpoint Inhibitors: An Analysis Based on a Systematic Review.
    Int J Dermatol. 2026;65:1420-1430.
    PubMed         Abstract available
    
    
53. KEMENY L
    Editor's Highlights-July 2026.
    Int J Dermatol. 2026;65:1355-1356.
    PubMed         Abstract available
    
    

    
    J Cutan Pathol

54. TANG H, DiNapoli S, Sukhadia P, Kim D, et al
    TFG-Containing Fusions in Melanocytic Tumors: From Polymorphic Read-Through Transcripts to Oncogenic Kinase Fusions.
    J Cutan Pathol. 2026 Jun 9. doi: 10.1111/cup.70162.
    PubMed         Abstract available
    
    
55. DOMMANN I, Restivo G, Kolm I, Sella F, et al
    Depicting the Immunological Landscape of Basal Cell Carcinoma Subtypes.
    J Cutan Pathol. 2026 Jun 9. doi: 10.1111/cup.70150.
    PubMed         Abstract available
    
    
56. JORDAN C, Hodges W, Russell L, Alhatem A, et al
    Dermatofibroma Hypocellularity Is Associated With Patient Age: A Retrospective Study of 307 Cases.
    J Cutan Pathol. 2026 Jun 7. doi: 10.1111/cup.70148.
    PubMed         Abstract available
    
    

    
    J Dermatol

57. YAHAGI Y, Fujimura T, Yoshida A, Asano Y, et al
    Hypopigmented Mycosis Fungoides With Childhood-Onset and Middle-Aged Onset: Two Case Reports Focusing on the Cutaneous Immune Microenvironment.
    J Dermatol. 2026 Jun 8. doi: 10.1111/1346-8138.70343.
    PubMed         Abstract available
    
    
58. OGUMA R, Koizumi S, Saeki Y, Aoyama K, et al
    Phenotypic Analysis of 26 Cultured TILs Derived From Japanese Melanoma Tissues.
    J Dermatol. 2026 Jun 10. doi: 10.1111/1346-8138.70346.
    PubMed         Abstract available
    
    
59. SAITO R, Sasaki W, Watanabe H, Hashimoto M, et al
    Extended-Interval Dosing and Discontinuation of Dupilumab in Atopic Dermatitis: A Real-World Retrospective Study.
    J Dermatol. 2026 Jun 11. doi: 10.1111/1346-8138.70350.
    PubMed         Abstract available
    
    
60. PENG Y, Guan Y, Lv K, Yang C, et al
    Mutation Analysis in Ten Cases With PNPLA1-Nonsyndromic Epidermal Differentiation Disorder: Evidence of a Founder Effect.
    J Dermatol. 2026;53:896-904.
    PubMed         Abstract available
    
    
61. ANDO T, Kamiya K, Kishimoto M, Sugihara N, et al
    Refractory Psoriatic Lesions in Japanese Patients With Biologics.
    J Dermatol. 2026;53:914-924.
    PubMed         Abstract available
    
    
62. MORADI A, Shakoei S, Hamzelou S, Nasimi M, et al
    Efficacy of 0.5% Timolol Maleate Eye Drops for the Treatment of Facial Rosacea: A Randomized, Triple-Blind, Placebo-Controlled Clinical Trial.
    J Dermatol. 2026;53:880-887.
    PubMed         Abstract available
    
    
63. YAMAMOTO A, Enomoto Y, Sakurai M, Watanabe O, et al
    Efficacy of Minimal Blistering Dose-Based Versus Conventional Excimer Laser Therapy for Vitiligo.
    J Dermatol. 2026;53:925-929.
    PubMed         Abstract available
    
    
64. TATEISHI F, Murayama N, Nakamuta R, Watanabe M, et al
    Erythropoietic Protoporphyria and Surgery: A Case of Successful Mastectomy With Perioperative Light Shielding Strategies Based on Light-Induced Hemolytic Threshold Assessment.
    J Dermatol. 2026;53:930-933.
    PubMed         Abstract available
    
    

    
    J Invest Dermatol

65. KIM N, Petukhova L, Winter DC, Tobin DJ, et al
    Activation of epidermal melanocytes in Hidradenitis Suppurativa.
    J Invest Dermatol. 2026 Jun 4:S0022-202X(26)01278.
    PubMed        
    
    
66. DLOVA NC, Cole-Adeife OM, Enechukwu NA, Madhumita M, et al
    The rise of the skin bleaching crisis: global perspectives.
    J Invest Dermatol. 2026 Jun 6:S0022-202X(26)01180.
    PubMed         Abstract available
    
    
67. WANG Y, Amber KT
    Hiding in plain sight: Pathogenic insights from nonlesional skin in gliptin-associated bullous pemphigoid.
    J Invest Dermatol. 2026 Jun 9:S0022-202X(26)01007.
    PubMed        
    
    
68. RIEBELMANN J, Schittek B
    The role of neutrophils and neutrophil extracellular traps in Staphylococcus aureus colonization in healthy and inflamed skin.
    J Invest Dermatol. 2026 Jun 9:S0022-202X(26)01050.
    PubMed         Abstract available
    
    
69. ZHAO Q, Leguina-Ruzzi A, Tominaga M, Kamata Y, et al
    Psychological stress delays inflammatory resolution and promotes sustained sensory sensitization during recovery from atopic dermatitis.
    J Invest Dermatol. 2026 Jun 9:S0022-202X(26)02596.
    PubMed        
    
    
70. HOU P, Che Y, Han J, Deming C, et al
    Permissive skin microbiomes in WHIM syndrome: HPV and pathogen expansion.
    J Invest Dermatol. 2026 Jun 8:S0022-202X(26)01309.
    PubMed         Abstract available
    
    
71. KOSUMI H, Rim C, Ito M
    Retinoic acids shift skin stem cell fate.
    J Invest Dermatol. 2026 Jun 10:S0022-202X(26)01049.
    PubMed        
    
    
72. SACKNOVITZ Y, Ma R, Zhou MH, Kent J, et al
    Serum proteomic and single-cell transcriptomic profiling reveals immunoproteomic features distinguishing early-stage mycosis fungoides from atopic dermatitis.
    J Invest Dermatol. 2026 Jun 10:S0022-202X(26)02599.
    PubMed        
    
    
73. KING AD, Fisher DE
    Identifying the drivers of genetic risk in patients with multiple primary melanoma.
    J Invest Dermatol. 2026 Jun 11:S0022-202X(26)01008.
    PubMed        
    
    
74. CALVAO J, Iselin C, Wasmayr J, Furtmuller C, et al
    Pathogenesis of cutaneous T-cell lymphoma: Malignant inflammation, immune reprogramming, and microenvironmental drivers.
    J Invest Dermatol. 2026 Jun 10:S0022-202X(26)01032.
    PubMed         Abstract available
    
    
75. RAMESSUR R, Gelfand JM
    Trials and tribulations of systemic inflammation and cardiovascular risk in psoriasis.
    J Invest Dermatol. 2026 Jun 10:S0022-202X(26)01206.
    PubMed        
    
    
76. GROSS L, Buddenkotte J, Joy F, Jochebeth A, et al
    Microdialysis-based metabolomic and proteomic profiling reveals signature variations for disease severity in psoriasis.
    J Invest Dermatol. 2026 Jun 10:S0022-202X(26)01192.
    PubMed         Abstract available
    
    
77. TAN SJ, Law CLD, Low S, Keith Tan KX, et al
    Development and applications of primary human sebocyte-derived sebaceous gland organoids: Sebaceous gland organoids.
    J Invest Dermatol. 2026 Jun 10:S0022-202X(26)01051.
    PubMed         Abstract available
    
    
78. ZEHTAB M, French LE, Lim HW, Fuller LC, et al
    A global health mandate for skin biology: Research opportunities for improved care after the World Health Assembly (WHA) skin diseases resolution.
    J Invest Dermatol. 2026 Jun 11:S0022-202X(26)01199.
    PubMed        
    
    

    
    Mycoses

79. BAROGH RE, Jeddi SA, Rokni GR, Fam HMT, et al
    Efficacy Evaluation of Luliconazole-Loaded Nanostructured Lipid Carriers in Treatment-Resistant Dermatophytosis: A Randomized Clinical Trial.
    Mycoses. 2026;69:e70196.
    PubMed         Abstract available
    
    
80. SONG G, Xie W, She X, Liu W, et al
    The Global Antifungal Susceptibility Epidemiology of Trichophyton indotineae Indicating Voriconazole as an Alternative Therapy for Recalcitrant Dermatophytosis.
    Mycoses. 2026;69:e70195.
    PubMed         Abstract available
    
    

    
    PLoS One

81. ZHENG L, Li W, Wang B, Wu T, et al
    Identification of potential key genes that respond to capsaicin treatment in ER-positive breast cancer: An integrated analysis.
    PLoS One. 2026;21:e0350841.
    PubMed         Abstract available
    
    
82. AL-DAMOOK N, Sakkal M, Khair M, Mousa WK, et al
    Mapping metabolic reprogramming in lung and breast cancer through integrative bioinformatics.
    PLoS One. 2026;21:e0350628.
    PubMed         Abstract available
    
    
83. OMORI K, Furukawa K, Usubuchi M, Hamada T, et al
    A multicenter, randomized, parallel-group confirmatory study protocol to evaluate the efficacy of Soft Protector CPC, a novel oral mucosal protectant, in preventing oral mucositis and alleviating pain in patients with breast cancer.
    PLoS One. 2026;21:e0350803.
    PubMed         Abstract available
    
    
84. EBERLE JV, Bickelhaupt S, Kapsner LA, Ohlmeyer S, et al
    Finite sample size errors in the context of multiple error sources in quantitative medical imaging: An evaluation for breast magnetic resonance diffusion-weighted imaging.
    PLoS One. 2026;21:e0341201.
    PubMed         Abstract available
    
    
85. NDENGUE CP, Atangana PJA, Ateba GR, Mandengue SH, et al
    Pre-analytical variables affecting breast cancer biomarker expression: A controlled single-specimen study of fixation duration, cold ischemia time, and fixative preparation in a low-resource setting.
    PLoS One. 2026;21:e0343185.
    PubMed         Abstract available
    
    
86. ANGELIS T, Philipsen PA, Ortner VK, Fredman G, et al
    A U-Net model for epidermal segmentation in optical coherence tomography images of actinic keratosis.
    PLoS One. 2026;21:e0346059.
    PubMed         Abstract available
    
    
87. MOKHTAR J, Alsuwaidi N, Hassane N, Eapen RM, et al
    Clinicopathological features and ethnic disparities of melanoma in the United Arab Emirates: 2017-2025.
    PLoS One. 2026;21:e0340749.
    PubMed         Abstract available
    
    
88. ZAIZEN Y, Koga T, Tsutsumi M, Kaieda S, et al
    Expression of melanoma differentiation-associated gene 5 in the epidermis and cutaneous deposition of complement C3 and immunoglobulins in patients with dermatomyositis.
    PLoS One. 2026;21:e0351248.
    PubMed         Abstract available
    
    
89. ZURIEGAT L, Itani R, Abu Hammour K, Abu-Farha R, et al
    Multidrug resistance and inappropriate empiric therapy as predictors of hospital stay in diabetic foot infections.
    PLoS One. 2026;21:e0350837.
    PubMed         Abstract available
    
    
90. GEOVANA NUNES ALVES R, Araujo Martins Ferreira B, Santos DO, da Silva Jesus L, et al
    Experience implementing a sporotrichosis surveillance and control program in free-roaming cats on a university campus.
    PLoS One. 2026;21:e0334204.
    PubMed         Abstract available
    
    
91. CHEN S, Yang X, Jiang S, Lin Y, et al
    Burden and temporal trends of female-specific cancers in China: A systematic analysis of the 2023 global burden of disease study.
    PLoS One. 2026;21:e0351539.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Dermatology is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum